Cuomo A, Forleo G, Ghodhbane T, Johnsen J, Montejo A, Oliveira C
Ann Gen Psychiatry. 2025; 24(1):13.
PMID: 40075512
PMC: 11905634.
DOI: 10.1186/s12991-025-00550-4.
Reznik A, Arbuzov A, Murin S
Consort Psychiatr. 2024; 1(2):43-51.
PMID: 39006904
PMC: 11240126.
DOI: 10.17650/2712-7672-2020-1-2-43-51.
Nan J, Grennan G, Ravichandran S, Ramanathan D, Mishra J
NPP Digit Psychiatry Neurosci. 2024; 2(1):10.
PMID: 38988507
PMC: 11230903.
DOI: 10.1038/s44277-024-00012-x.
Fulford D, Marsch L, Pratap A
Biol Psychiatry. 2024; 96(8):659-665.
PMID: 38960019
PMC: 11410508.
DOI: 10.1016/j.biopsych.2024.06.026.
Teles M, Maximo J, Lahti A, Kraguljac N
Schizophr Bull. 2024; 50(4):839-847.
PMID: 38666705
PMC: 11283198.
DOI: 10.1093/schbul/sbae054.
Convergent and divergent genes expression profiles associated with brain-wide functional connectome dysfunction in deficit and non-deficit schizophrenia.
Zhou C, Tang X, Yu M, Zhang H, Zhang X, Gao J
Transl Psychiatry. 2024; 14(1):124.
PMID: 38413564
PMC: 10899251.
DOI: 10.1038/s41398-024-02827-w.
Efficacy of Using Intermittent Theta Burst Stimulation to Treat Negative Symptoms in Patients with Schizophrenia-A Systematic Review and Meta-Analysis.
Tan X, Goh S, Lee J, Vanniasingham S, Brunelin J, Lee J
Brain Sci. 2024; 14(1).
PMID: 38248233
PMC: 10813174.
DOI: 10.3390/brainsci14010018.
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses.
Banaj N, Vecchio D, Piras F, De Rossi P, Bustillo J, Ciufolini S
Mol Psychiatry. 2023; 28(10):4363-4373.
PMID: 37644174
PMC: 10827665.
DOI: 10.1038/s41380-023-02221-w.
Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis.
Fekih-Romdhane F, Hajje R, Haddad C, Hallit S, Azar J
BMC Psychiatry. 2023; 23(1):595.
PMID: 37582728
PMC: 10428523.
DOI: 10.1186/s12888-023-05101-3.
Social Withdrawal, Loneliness, and Health in Schizophrenia: Psychological and Neural Mechanisms.
Fulford D, Holt D
Schizophr Bull. 2023; 49(5):1138-1149.
PMID: 37419082
PMC: 10483452.
DOI: 10.1093/schbul/sbad099.
Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status.
Tran T, Spilka M, Raugh I, Strauss G, Bearden C, Cadenhead K
Schizophr Bull Open. 2023; 4(1):sgad014.
PMID: 37362552
PMC: 10287168.
DOI: 10.1093/schizbullopen/sgad014.
Transcranial Alternating Current Stimulation Alters Auditory Steady-State Oscillatory Rhythms and Their Cross-Frequency Couplings.
de la Salle S, Choueiry J, Payumo M, Devlin M, Noel C, Abozmal A
Clin EEG Neurosci. 2023; 55(3):329-339.
PMID: 37306065
PMC: 11020127.
DOI: 10.1177/15500594231179679.
Brain Network Topology in Deficit and Non-Deficit Schizophrenia: Application of Graph Theory to Local and Global Indices.
Vecchio D, Piras F, Ciullo V, Piras F, Natalizi F, Ducci G
J Pers Med. 2023; 13(5).
PMID: 37240969
PMC: 10221724.
DOI: 10.3390/jpm13050799.
The efficacy of homestyle rehabilitation on negative symptoms in chronic schizophrenia: A randomized controlled trial.
Chai J, Liu F, Liu L, Hu N, Huang W, Wang H
Front Psychiatry. 2023; 14:1138794.
PMID: 37139315
PMC: 10149672.
DOI: 10.3389/fpsyt.2023.1138794.
Case series: Cariprazine in early-onset schizophrenia.
Ivanova E, Maslinkova D, Polnareva N, Milanova V
Front Psychiatry. 2023; 14:1155518.
PMID: 37124247
PMC: 10140560.
DOI: 10.3389/fpsyt.2023.1155518.
Sleep Problems, Suicidal Ideation, and Psychopathology in First-Episode Psychosis.
Ayers N, McCall W, Miller B
Schizophr Bull. 2023; 50(2):286-294.
PMID: 37086485
PMC: 10919767.
DOI: 10.1093/schbul/sbad045.
Using support vector machine to explore the difference of function connection between deficit and non-deficit schizophrenia based on gray matter volume.
Zhu W, Wang Z, Yu M, Zhang X, Zhang Z
Front Neurosci. 2023; 17:1132607.
PMID: 37051145
PMC: 10083255.
DOI: 10.3389/fnins.2023.1132607.
Intra and inter-individual variability in functional connectomes of patients with First Episode of Psychosis.
Tepper A, Vasquez Nunez J, Ramirez-Mahaluf J, Aguirre J, Barbagelata D, Maldonado E
Neuroimage Clin. 2023; 38:103391.
PMID: 37003128
PMC: 10102560.
DOI: 10.1016/j.nicl.2023.103391.
Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone.
Gao Z, Xiu M, Liu J, Wu F, Zhang X
Schizophrenia (Heidelb). 2023; 9(1):17.
PMID: 36949120
PMC: 10033648.
DOI: 10.1038/s41537-023-00346-z.
Challenges and Considerations in Treating Negative and Cognitive Symptoms of Schizophrenia Spectrum Disorders.
Krauss A, Bernard J, Okusaga O
Fed Pract. 2022; 39(11):448-453.
PMID: 36582498
PMC: 9794169.
DOI: 10.12788/fp.0338.